Medicare GLP-1 Discount Misses the Very Sick It Aims to Help
TL;DR
Medicare’s 18-month GLP-1 Bridge offers weight-loss drugs for about $50 a month, but anyone with an FDA-approved medical indication for GLP-1s (like sleep apnea or diabetes) is redirected to costly Part D plans, leaving potentially 5.9 million beneficiaries excluded and highlighting a gap between cost relief and real medical need.
- The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don’t Qualify KFF Health News
- Lilly covers aging and obesity in new GLP-1 access campaign Fierce Pharma
- Medicare’s GLP-1 discount program excluded millions of patients — Fortune UA.NEWS
- Eli Lilly Debuts Advertisement Selling GLP-1s to Medicare Enrollees Yahoo
- Medicare's 50 Dollar GLP-1 Price Locks Out Nearly Six Million People Who Have a Qualifying Diagnosis Medical Daily
Want the full story? Read the original reporting
Read on KFF Health News